ArticleCell and tissue banking2025
In vitro evaluation of the nanofibers developed for peripheral nerve regeneration.
Article in Cell and tissue banking, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In tissue engineering, natural and synthetic nanofibers that can regenerate body damage have been successfully used in the repair of many lesion types, including peripheral neural lesions, in recent years. So, we developed three different nanofibers that we think can regenerate peripheral nerve damage. Three different nanofibers based on biodegradable poly-ε-caprolactone (PCL); Pure PCL (PCL) nanofiber, 70% PCL and 30% bioactive glass (PCL/BG) hybrid nanofiber, and 0.1% vitamin B12 added (PCL/BG)-B12 hybrid nanofiber were produced by electrospinning. Sol-gel method was used in the synthesis of biomaterials containing bioactive glass. The nanofibers were characterized by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), and fourier transform infrared spectroscopy (FT-IR). Cell viability assays were performed with healthy L929 fibroblast cells and PC12 cells to evaluate the biocompatibility of nanofibers. Neuronal differentiation of PC12 cells were stimulated by nerve growth factor (NGF). To assess the differentiation levels of PC12 cells, the length of neurites and number of outgrowing neurites per cell was evaluated morphologically, and NGF production levels of the cells were determined by ELISA. The results suggest that these biocompatible nanofibers stimulated PC12 cell survival and neuronal differentiation. Among these scaffolds, PCL/BG-B12 nanofibers strikingly triggered NGF production of PC12 cells as a hallmark of neuroregeneration. Thus, the nanofibers are capable of neuroprotective properties due to their safe, supporting proliferation, and NGF-releasing capacity. Additionally, it could be suggested that the PCL/BG nanofiber and vitamin B12 have the potential to be used in further studies for neurodegenerative diseases.
Indexed as
Identifiers
41091282What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.